rs111787313
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001034853.2(RPGR):c.3219C>T(p.Gly1073=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0402 in 1,205,849 control chromosomes in the GnomAD database, including 1,654 homozygotes. There are 16,653 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.064 ( 286 hom., 2046 hem., cov: 21)
Exomes 𝑓: 0.038 ( 1368 hom. 14607 hem. )
Consequence
RPGR
NM_001034853.2 synonymous
NM_001034853.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.55
Genes affected
RPGR (HGNC:10295): (retinitis pigmentosa GTPase regulator) This gene encodes a protein with a series of six RCC1-like domains (RLDs), characteristic of the highly conserved guanine nucleotide exchange factors. The encoded protein is found in the Golgi body and interacts with RPGRIP1. This protein localizes to the outer segment of rod photoreceptors and is essential for their viability. Mutations in this gene have been associated with X-linked retinitis pigmentosa (XLRP). Multiple alternatively spliced transcript variants that encode different isoforms of this gene have been reported, but the full-length natures of only some have been determined. [provided by RefSeq, Dec 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant X-38285780-G-A is Benign according to our data. Variant chrX-38285780-G-A is described in ClinVar as [Benign]. Clinvar id is 403390.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-38285780-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-3.55 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.133 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPGR | NM_001034853.2 | c.3219C>T | p.Gly1073= | synonymous_variant | 15/15 | ENST00000645032.1 | NP_001030025.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPGR | ENST00000645032.1 | c.3219C>T | p.Gly1073= | synonymous_variant | 15/15 | NM_001034853.2 | ENSP00000495537 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0644 AC: 6956AN: 107954Hom.: 287 Cov.: 21 AF XY: 0.0663 AC XY: 2038AN XY: 30734
GnomAD3 genomes
AF:
AC:
6956
AN:
107954
Hom.:
Cov.:
21
AF XY:
AC XY:
2038
AN XY:
30734
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0800 AC: 14513AN: 181522Hom.: 822 AF XY: 0.0722 AC XY: 4844AN XY: 67090
GnomAD3 exomes
AF:
AC:
14513
AN:
181522
Hom.:
AF XY:
AC XY:
4844
AN XY:
67090
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0379 AC: 41559AN: 1097849Hom.: 1368 Cov.: 34 AF XY: 0.0402 AC XY: 14607AN XY: 363293
GnomAD4 exome
AF:
AC:
41559
AN:
1097849
Hom.:
Cov.:
34
AF XY:
AC XY:
14607
AN XY:
363293
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0645 AC: 6963AN: 108000Hom.: 286 Cov.: 21 AF XY: 0.0664 AC XY: 2046AN XY: 30792
GnomAD4 genome
AF:
AC:
6963
AN:
108000
Hom.:
Cov.:
21
AF XY:
AC XY:
2046
AN XY:
30792
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 09, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 03, 2018 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Primary ciliary dyskinesia Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Retinal dystrophy Benign:1
Benign, criteria provided, single submitter | research | Dept Of Ophthalmology, Nagoya University | Oct 01, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at